NCT07170059View on ClinicalTrials.gov

Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

November 1, 2026

Study Completion Date

October 1, 2030

Conditions

Lung Cancer

Interventions

BIOLOGICAL

herpes zoster vaccine

Receive the herpes zoster vaccine; Do not receive the herpes zoster vaccine

All Listed Sponsors

lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER